# NDUFS2

## Overview
The NDUFS2 gene encodes the NADH:ubiquinone oxidoreductase core subunit S2, a vital component of mitochondrial complex I, which is integral to the electron transport chain in human cells. This protein is categorized as a core subunit within the hydrogenase module of complex I, facilitating the transfer of electrons from NADH to ubiquinone, a key step in oxidative phosphorylation and ATP production (Vogel2007Human; Ngu2012A). The NDUFS2 protein is essential for the assembly and stability of complex I, playing a significant role in maintaining cellular energy metabolism and respiratory function (Vogel2007Human). Mutations in the NDUFS2 gene are linked to mitochondrial disorders such as Leigh syndrome, highlighting its clinical significance in neurodegenerative and vascular diseases (Ngu2012A). Additionally, NDUFS2 is involved in oxygen sensing and hypoxic pulmonary vasoconstriction, further underscoring its importance in cellular and systemic physiological processes (DunhamSnary2019Ndufs2).

## Structure
The NDUFS2 protein is a core subunit of mitochondrial complex I, which plays a crucial role in the electron transport chain. It is a 49 kDa protein involved in electron transfer processes, particularly in the transfer of electrons from the terminal N2 cluster to ubiquinone (Fiedorczuk2018Mammalian). The protein's structure includes a β1-β2 loop, which is significant for its catalytic function and affects the quinone-binding site (Fiedorczuk2018Mammalian). 

Mutations in NDUFS2, such as Arg118Gln, Arg138Gln, and Ala224Val, are located around the N2 cluster and can impact the redox potential and electron transfer rates. Arg118 is involved in a dimethylation process that contributes to the high reduction potential of the N2 cluster, while Arg138 is positioned close to the N2 cluster, affecting its properties. Ala224, although not directly influencing the N2 cluster, is adjacent to His223, a proposed redox-Bohr group, affecting the cluster's environment (Fiedorczuk2018Mammalian).

The NDUFS2 subunit is part of the peripheral matrix arm of complex I, which includes other core subunits like NDUFS3, NDUFS7, and NDUFS8, forming an assembly intermediate in the early stages of complex I assembly (Mckenzie2010Assembly).

## Function
The NDUFS2 gene encodes a core subunit of mitochondrial complex I, also known as NADH:ubiquinone oxidoreductase, which is a crucial component of the electron transport chain in human cells. This complex is responsible for transferring electrons from NADH to ubiquinone, a process that is essential for ATP production through oxidative phosphorylation (Vogel2007Human; Ngu2012A). NDUFS2 is part of the hydrogenase module within complex I, which guides electrons to the electron acceptor ubiquinone, contributing to the formation of a proton gradient across the mitochondrial inner membrane necessary for ATP synthesis (Vogel2007Human).

In healthy human cells, NDUFS2 plays a critical role in maintaining normal complex I activity and stability, ensuring efficient energy production (Ngu2012A). It is involved in the assembly of the peripheral arm of complex I, which is essential for the proper assembly and function of the entire complex (Vogel2007Human). The protein is active in the inner mitochondrial membrane, where it facilitates the coupling of electron transfer with proton pumping, a key function in cellular respiration and energy metabolism (Vogel2007Human; Ngu2012A).

## Clinical Significance
Mutations in the NDUFS2 gene are associated with several severe disorders, primarily due to mitochondrial complex I deficiency. One of the most notable conditions linked to NDUFS2 mutations is Leigh syndrome, a severe neurological disorder characterized by progressive neurodegeneration. Patients with Leigh syndrome often exhibit symptoms such as progressive encephalopathy and hypertrophic cardiomyopathy. A specific mutation, Asp446Asn, has been identified in the NDUFS2 gene, which leads to a catalytic defect in complex I, reducing its enzymatic activity despite normal levels of the complex. This mutation is located near the coenzyme Q binding pocket, potentially interfering with coenzyme Q reduction or its coupling with proton pumping (Ngu2012A).

In addition to its role in Leigh syndrome, NDUFS2 is implicated in oxygen sensing and hypoxic pulmonary vasoconstriction (HPV). Alterations in NDUFS2 expression can affect the production of reactive oxygen species (ROS) and disrupt normal oxygen-sensing pathways in pulmonary artery smooth muscle cells. This disruption can lead to impaired hypoxic responses, mimicking conditions of chronic hypoxia and affecting vascular tone regulation (DunhamSnary2019Ndufs2). These findings highlight the critical role of NDUFS2 in both neurological and vascular pathologies.

## Interactions
NDUFS2, a core subunit of mitochondrial complex I, is involved in several critical interactions within the electron transport chain. It is part of the assembly of complex I, interacting with other core subunits such as NDUFS3, NDUFS7, and NDUFS8 during the early stages of complex I assembly (Mckenzie2010Assembly). These interactions are essential for the proper formation and function of the complex.

NDUFS2 also plays a role in oxygen sensing and hypoxic pulmonary vasoconstriction (HPV) by interacting with other components of the electron transport chain. It is crucial for the production of mitochondrial-derived hydrogen peroxide (H2O2), which is a key factor in the oxygen-sensing mechanism of pulmonary artery smooth muscle cells (PASMC) (DunhamSnary2019Ndufs2). The knockdown of NDUFS2 in PASMC leads to a decrease in mitochondrial H2O2 production, highlighting its role in regulating mitochondrial reactive oxygen species (ROS) production during hypoxia (DunhamSnary2019Ndufs2).

In the context of cancer, NDUFS2 is upregulated by the metastasis-promoting protein S100A4, which enhances mitochondrial complex I activity and promotes the invasive capacity of lung cancer cells (Liu2019S100A4). This interaction underscores the role of NDUFS2 in modulating mitochondrial metabolism and its potential impact on cancer progression (Liu2019S100A4).


## References


[1. (Ngu2012A) Lock Hock Ngu, Leo G. Nijtmans, Felix Distelmaier, Hanka Venselaar, Sjenet E. van Emst-de Vries, Mariël A.M. van den Brand, Berendien J.M. Stoltenborg, Liesbeth T. Wintjes, Peter H. Willems, Lambertus P. van den Heuvel, Jan A. Smeitink, and Richard J.T. Rodenburg. A catalytic defect in mitochondrial respiratory chain complex i due to a mutation in ndufs2 in a patient with leigh syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1822(2):168–175, February 2012. URL: http://dx.doi.org/10.1016/j.bbadis.2011.10.012, doi:10.1016/j.bbadis.2011.10.012. This article has 24 citations.](https://doi.org/10.1016/j.bbadis.2011.10.012)

[2. (Mckenzie2010Assembly) Matthew Mckenzie and Michael T. Ryan. Assembly factors of human mitochondrial complex i and their defects in disease. IUBMB Life, 62(7):497–502, April 2010. URL: http://dx.doi.org/10.1002/iub.335, doi:10.1002/iub.335. This article has 115 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/iub.335)

[3. (Vogel2007Human) Rutger O. Vogel, Jan A.M. Smeitink, and Leo G.J. Nijtmans. Human mitochondrial complex i assembly: a dynamic and versatile process. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1767(10):1215–1227, October 2007. URL: http://dx.doi.org/10.1016/j.bbabio.2007.07.008, doi:10.1016/j.bbabio.2007.07.008. This article has 123 citations.](https://doi.org/10.1016/j.bbabio.2007.07.008)

[4. (Fiedorczuk2018Mammalian) Karol Fiedorczuk and Leonid A. Sazanov. Mammalian mitochondrial complex i structure and disease-causing mutations. Trends in Cell Biology, 28(10):835–867, October 2018. URL: http://dx.doi.org/10.1016/j.tcb.2018.06.006, doi:10.1016/j.tcb.2018.06.006. This article has 124 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tcb.2018.06.006)

[5. (DunhamSnary2019Ndufs2) Kimberly J. Dunham-Snary, Danchen Wu, François Potus, Edward A. Sykes, Jeffrey D. Mewburn, Rebecca L. Charles, Philip Eaton, Richard A. Sultanian, and Stephen L. Archer. Ndufs2, a core subunit of mitochondrial complex i, is essential for acute oxygen-sensing and hypoxic pulmonary vasoconstriction. Circulation Research, 124(12):1727–1746, June 2019. URL: http://dx.doi.org/10.1161/circresaha.118.314284, doi:10.1161/circresaha.118.314284. This article has 70 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/circresaha.118.314284)

[6. (Liu2019S100A4) Lili Liu, Lei Qi, Teresa Knifley, Dava W. Piecoro, Piotr Rychahou, Jinpeng Liu, Mihail I. Mitov, Jeremiah Martin, Chi Wang, Jianrong Wu, Heidi L. Weiss, D. Allan Butterfield, B. Mark Evers, Kathleen L. O’Connor, and Min Chen. S100a4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex i protein ndufs2. Journal of Biological Chemistry, 294(18):7516–7527, May 2019. URL: http://dx.doi.org/10.1074/jbc.ra118.004365, doi:10.1074/jbc.ra118.004365. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra118.004365)